Our in vitro HepG2 model document presents the technical details of the high glucose-induced cell injury model. This model can support customers' in vitro screening of antidiabetic drug candidates.

This promotional material will provide you with a detailed presentation of:

• Clear modeling protocol: Detailed information on the induction method, including glucose concentration (30-120 mM), stimulation duration (24-48 hours), and control conditions (5.5 mM glucose).
• Key validation data: Quantitative demonstration of model success, showing that cell viability significantly decreases to 35%-75% of the control group under high glucose stimulation.
• Ready-to-use experimental system: A straightforward in vitro platform that allows you to assess the protective effects of your drug candidates against glucose-induced cellular damage.

This validated model provides a robust, reproducible experimental foundation to accelerate your screening efforts and drive successful outcomes in diabetes research programs.

Download the brochure to access complete model parameters and validation data. Then contact us to discuss how this in vitro model can be tailored to your drug development program.

You might be interested in...